Literature DB >> 15161646

Novel NKX2-5 mutations in diseased heart tissues of patients with cardiac malformations.

Stella Marie Reamon-Buettner1, Hartmut Hecker, Katharina Spanel-Borowski, Steffen Craatz, Eberhard Kuenzel, Juergen Borlak.   

Abstract

NKX2-5 is a homeodomain-containing transcription factor important in cardiac development. Familial mutations in the NKX2-5 gene are associated with cardiac abnormalities, but mutations are rare in sporadic cases. We studied the pathology and molecular genetics of NKX2-5 in diseased heart tissues of 68 patients with complex congenital heart disease (CHD), particularly atrial (ASD), ventricular (VSD), and atrioventricular septal defects (AVSD). We also studied DNA extracted from 16 normal hearts, as well as lymphocytic DNA from 50 healthy volunteers, 7 families, and 4 unrelated individuals with CHD. Direct sequencing revealed 53 NKX2-5 mutations in the diseased heart tissues, including nonsynonymous substitutions in the homeodomain of NKX2-5. We found common mutations among unrelated patients, but certain mutations were specific to VSDs and AVSDs. Many patients had multiple NKX2-5 mutations, up to 14 nonsynonymous mutations per patient in VSDs. Importantly, these nonsynonymous mutations were mainly absent in normal heart tissues of the same CHD patients, thus indicating somatic origin and mosaicism of mutations. Further, observed mutations were completely absent in normal hearts and lymphocytic DNA of healthy individuals. Our findings provide new insights for somatic NKX2-5 mutations to be of importance in congenital heart disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15161646      PMCID: PMC1615780          DOI: 10.1016/S0002-9440(10)63770-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

1.  Molecular evolution of the homeodomain family of transcription factors.

Authors:  S Banerjee-Basu; A D Baxevanis
Journal:  Nucleic Acids Res       Date:  2001-08-01       Impact factor: 16.971

2.  Tandem duplication mosaicism: characterization of a mosaic dup(5q) and review.

Authors:  K A Rauen; S M Bitts; L Li; M Golabi; P D Cotter
Journal:  Clin Genet       Date:  2001-11       Impact factor: 4.438

3.  Two novel frameshift mutations in NKX2.5 result in novel features including visceral inversus and sinus venosus type ASD.

Authors:  Y Watanabe; D W Benson; S Yano; T Akagi; M Yoshino; J C Murray
Journal:  J Med Genet       Date:  2002-11       Impact factor: 6.318

4.  The combinatorial activities of Nkx2.5 and dHAND are essential for cardiac ventricle formation.

Authors:  H Yamagishi; C Yamagishi; O Nakagawa; R P Harvey; E N Olson; D Srivastava
Journal:  Dev Biol       Date:  2001-11-15       Impact factor: 3.582

5.  Functional analyses of three Csx/Nkx-2.5 mutations that cause human congenital heart disease.

Authors:  W Zhu; I Shiojima; Y Hiroi; Y Zou; H Akazawa; M Mizukami; H Toko; Y Yazaki; R Nagai; I Komuro
Journal:  J Biol Chem       Date:  2000-11-10       Impact factor: 5.157

6.  Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: associations with atrial septal defect and hypoplastic left heart syndrome.

Authors:  David A Elliott; Edwin P Kirk; Thomas Yeoh; Suchitra Chandar; Fiona McKenzie; Peter Taylor; Paul Grossfeld; Diane Fatkin; Owen Jones; Peter Hayes; Michael Feneley; Richard P Harvey
Journal:  J Am Coll Cardiol       Date:  2003-06-04       Impact factor: 24.094

7.  Novel point mutation in the cardiac transcription factor CSX/NKX2.5 associated with congenital heart disease.

Authors:  Yuichi Ikeda; Yukio Hiroi; Toru Hosoda; Toshinori Utsunomiya; Shuzo Matsuo; Tsuyoshi Ito; Jun-ichi Inoue; Tetsuya Sumiyoshi; Hiroyuki Takano; Ryozo Nagai; Issei Komuro
Journal:  Circ J       Date:  2002-06       Impact factor: 2.993

8.  NKX2.5 mutations in patients with congenital heart disease.

Authors:  Doff B McElhinney; Elizabeth Geiger; Joshua Blinder; D Woodrow Benson; Elizabeth Goldmuntz
Journal:  J Am Coll Cardiol       Date:  2003-11-05       Impact factor: 24.094

9.  Progressive AV-block and anomalous venous return among cardiac anomalies associated with two novel missense mutations in the CSX/NKX2-5 gene.

Authors:  Ilse Gutierrez-Roelens; Thierry Sluysmans; Marc Gewillig; Koen Devriendt; Miikka Vikkula
Journal:  Hum Mutat       Date:  2002-07       Impact factor: 4.878

Review 10.  The incidence of congenital heart disease.

Authors:  Julien I E Hoffman; Samuel Kaplan
Journal:  J Am Coll Cardiol       Date:  2002-06-19       Impact factor: 24.094

View more
  23 in total

1.  Somatic mutations in cardiac malformations.

Authors:  S M Reamon-Buettner; J Borlak
Journal:  J Med Genet       Date:  2006-08       Impact factor: 6.318

2.  [NKX2.5 and TBX5 gene mutations in in vitro fertilization children with congenital heart disease].

Authors:  Jing-Hui Yang; Xiao-Yan Xu; Hong-Ying Mi; Yan Jiang; Xin-Mei Ma; Li Li
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2017-06

Review 3.  Transcription factor pathways and congenital heart disease.

Authors:  David J McCulley; Brian L Black
Journal:  Curr Top Dev Biol       Date:  2012       Impact factor: 4.897

4.  Targeted deep sequencing reveals no definitive evidence for somatic mosaicism in atrial fibrillation.

Authors:  Jason D Roberts; James Longoria; Annie Poon; Michael H Gollob; Thomas A Dewland; Pui-Yan Kwok; Jeffrey E Olgin; Rahul C Deo; Gregory M Marcus
Journal:  Circ Cardiovasc Genet       Date:  2014-11-18

Review 5.  The genetics of isolated congenital heart disease.

Authors:  Shannon N Nees; Wendy K Chung
Journal:  Am J Med Genet C Semin Med Genet       Date:  2019-12-26       Impact factor: 3.908

6.  The Congenital Heart Disease Genetic Network Study: rationale, design, and early results.

Authors:  Bruce Gelb; Martina Brueckner; Wendy Chung; Elizabeth Goldmuntz; Jonathan Kaltman; Juan Pablo Kaski; Richard Kim; Jennie Kline; Laura Mercer-Rosa; George Porter; Amy Roberts; Ellen Rosenberg; Howard Seiden; Christine Seidman; Lynn Sleeper; Sharon Tennstedt; Jonathan Kaltman; Charlene Schramm; Kristin Burns; Gail Pearson; Ellen Rosenberg
Journal:  Circ Res       Date:  2013-02-15       Impact factor: 17.367

7.  Cyclic stretch of embryonic cardiomyocytes increases proliferation, growth, and expression while repressing Tgf-β signaling.

Authors:  Indroneal Banerjee; Katrina Carrion; Ricardo Serrano; Jeffrey Dyo; Roman Sasik; Sean Lund; Erik Willems; Seema Aceves; Rudolph Meili; Mark Mercola; Ju Chen; Alexander Zambon; Gary Hardiman; Taylor A Doherty; Stephan Lange; Juan C del Álamo; Vishal Nigam
Journal:  J Mol Cell Cardiol       Date:  2014-11-13       Impact factor: 5.000

8.  An excess of deleterious variants in VEGF-A pathway genes in Down-syndrome-associated atrioventricular septal defects.

Authors:  Christine Ackerman; Adam E Locke; Eleanor Feingold; Benjamin Reshey; Karina Espana; Janita Thusberg; Sean Mooney; Lora J H Bean; Kenneth J Dooley; Clifford L Cua; Roger H Reeves; Stephanie L Sherman; Cheryl L Maslen
Journal:  Am J Hum Genet       Date:  2012-10-05       Impact factor: 11.025

9.  Novel and highly lethal NKX2.5 missense mutation in a family with sudden death and ventricular arrhythmia.

Authors:  Jennifer L Perera; Nicole M Johnson; Daniel P Judge; Jane E Crosson
Journal:  Pediatr Cardiol       Date:  2014-06-01       Impact factor: 1.655

10.  Karyotypic and molecular genetic changes associated with fetal cardiovascular abnormalities: results of a retrospective 4-year ultrasonic diagnosis study.

Authors:  Bihui Bao; Yu Wang; Hua Hu; Hong Yao; Yuyan Li; Shuai Tang; Lihong Zheng; Yan Xu; Zhiqing Liang
Journal:  Int J Biol Sci       Date:  2013-05-09       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.